🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. Panitumumab + TAS-102

    Takeda

    Colorectal Cancer

    phase 2 small molecule completed

    1 trial

  2. Pevonedistat

    Takeda

    Acute Myeloid Leukemia (AML)

    phase 2 small molecule completed

    2 trials

  3. Pevonedistat

    Takeda

    Myelodysplastic Syndromes (MDS)

    phase 2 small molecule terminated

    1 trial

  4. Pioglitazone

    Takeda

    Depressive Disorder, Major

    phase 2 small molecule completed

    1 trial

  5. Pioglitazone

    Takeda

    Inflammation

    phase 2 small molecule completed

    1 trial

  6. Pioglitazone

    Takeda

    Chronic Pancreatitis

    phase 2 small molecule completed

    1 trial

  7. Pioglitazone

    Takeda

    Oxidative Stress

    phase 2 small molecule completed

    1 trial

  8. Pioglitazone and atorvastatin

    Takeda

    Cardiovascular Diseases

    phase 2 small molecule completed

    1 trial

  9. Pioglitazone and azilsartan

    Takeda

    Diabetes Mellitus

    phase 2 small molecule completed

    1 trial

  10. Placebo

    Takeda

    Narcolepsy Type 2

    phase 2 small molecule completed

    1 trial

  11. Placebo

    Takeda

    Celiac Disease

    phase 2 small molecule completed

    1 trial

  12. Placebo

    Takeda

    Gout

    phase 2 small molecule completed

    1 trial

  13. Placebo

    Takeda

    Essential Hypertension

    phase 2 small molecule completed

    1 trial

  14. Placebo

    Takeda

    Endometriosis

    phase 2 small molecule completed

    2 trials

  15. Placebo

    Takeda

    Ulcerative Colitis

    phase 2 small molecule completed

    1 trial

  16. Placebo

    Takeda

    Graft Rejection

    phase 2 mab completed

    1 trial

  17. Placebo

    Takeda

    Primary Immune Thrombocytopenia

    phase 2 small molecule completed

    1 trial

  18. Ponatinib

    Takeda

    Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)

    phase 2 small molecule terminated

    1 trial

  19. Ponatinib

    Takeda

    Myeloid Leukemia, Chronic, Chronic Phase

    phase 2 small molecule completed

    1 trial

  20. Ponatinib

    Takeda

    Chronic Myeloid Leukemia

    phase 2 small molecule completed

    1 trial

  21. Ponatinib

    Takeda

    GIST

    phase 2 small molecule completed

    1 trial

  22. Pramlintide+Metreleptin

    Takeda

    Obesity

    phase 2 small molecule terminated

    1 trial

  23. Purified Inactivated Zika Virus Vaccine (PIZV)

    Takeda

    Healthy Volunteers

    phase 2 mab terminated

    1 trial

  24. RECOMBINANT ADAMTS13 (rADAMTS13), -, RITUXIMAB

    Takeda

    Immune-mediated thrombotic thrombocytopenic purpura (iTTP)

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources